Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: ChiRex acetaminophen business

This article was originally published in The Tan Sheet

Executive Summary

ChiRex acetaminophen business: Being sold by the contract manufacturing organization to Rhone-Poulenc Chimie SA, Wellesley, Mass.-based ChiRex announces April 9. Under the agreement, for which ChiRex expects to receive net proceeds of $6.3 mil., the company will continue to manufacture acetaminophen (APAP) for RPC "for a period to effect a seamless transfer of customers," ChiRex reports. The sale reflects ChiRex' intention to divest low-margin, low-growth, non-core products and focus on being a CMO for the pharmaceutical industry, the company says. The APAP production facility is in Dudley, Northumberland, England...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS086911

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel